AHR and lung carcinoma: Notably, the crosstalk between AhR and JAK/STAT signaling cascades blunts anti-tumor immune responses and promotes malignancies such as lung cancer, melanoma, glioblastoma, and oral squamous cell carcinoma (116, 119, 120).